A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment ofSymptomatic Deep Vein Thrombosis and Pulmonary Embolism
Phase 3
Completed
- Conditions
- Health Condition 1: null- Symptomatic Deep Vein Thrombosis and Pulmonary Embolism
- Registration Number
- CTRI/2009/091/000047
- Lead Sponsor
- This trial is being sponsored by BristolMyers Squibb
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 2408
Inclusion Criteria
Men and women ≥ 18 years of age
Clinical diagnosis of DVT or PE
Exclusion Criteria
Contraindications for enoxaparin or warfarin
Active bleeding or high risk for serious bleeding
Short life expectancy
Uncontrolled high blood pressure
Significantly impaired kidney or liver function
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method